Key Insights

Highlights

Success Rate

82% trial completion

Published Results

42 trials with published results (14%)

Research Maturity

80 completed trials (26% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

5.9%

18 terminated out of 303 trials

Success Rate

81.6%

-5.0% vs benchmark

Late-Stage Pipeline

6%

17 trials in Phase 3/4

Results Transparency

53%

42 of 80 completed with results

Key Signals

42 with results82% success18 terminated

Data Visualizations

Phase Distribution

220Total
Not Applicable (118)
Early P 1 (11)
P 1 (36)
P 2 (38)
P 3 (15)
P 4 (2)

Trial Status

Recruiting94
Completed80
Active Not Recruiting70
Terminated18
Not Yet Recruiting16
Withdrawn11

Trial Success Rate

81.6%

Benchmark: 86.6%

Based on 80 completed trials

Clinical Trials (303)

Showing 20 of 20 trials
NCT05334069Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT06880861Recruiting

Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers

NCT06265285Phase 2Recruiting

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

NCT04387656Active Not Recruiting

NCI COVID-19 in Cancer Patients, NCCAPS Study

NCT06126276Phase 2Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

NCT03996265Phase 3Active Not Recruiting

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

NCT07285044Phase 2Recruiting

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

NCT04888988Not ApplicableActive Not Recruiting

Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy

NCT04438382Phase 2Terminated

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

NCT07737314Not ApplicableNot Yet Recruiting

Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study

NCT05103358Phase 2Completed

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

NCT04170075Not ApplicableCompleted

Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy

NCT06855524Phase 2Recruiting

Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer

NCT07835841Not ApplicableNot Yet Recruiting

Blessing Stem Cells to Improve Spiritual Well Being and Quality of Life for Patients Undergoing Hematopoietic Stem Cell Transplantation

NCT06587100Recruiting

Wearable Activity Tracking to Curb Hospitalizations

NCT06009926Phase 2Active Not Recruiting

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

NCT03816345Phase 1Recruiting

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT05477784Not ApplicableTerminated

Cancer Parenting Program for the Enhancement of the Quality of Life of Patients With Advanced Cancer and Their Children

NCT07545291Not ApplicableNot Yet Recruiting

A Spiritual Health Intervention (PATH) for Improving Spiritual, Religious and Emotional Distress in Cancer Patients

NCT04242095Recruiting

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Scroll to load more

Research Network

Activity Timeline